Vandenbroucke and Pearce respond to "incident and prevalent exposures and causal inference".
作者信息
Vandenbroucke Jan, Pearce Neil
出版信息
Am J Epidemiol. 2015 Nov 15;182(10):846-7. doi: 10.1093/aje/kwv219. Epub 2015 Oct 26.
Abstract
摘要
相似文献
1
Vandenbroucke and Pearce respond to "incident and prevalent exposures and causal inference".
Am J Epidemiol. 2015 Nov 15;182(10):846-7. doi: 10.1093/aje/kwv219. Epub 2015 Oct 26.
2
Point: incident exposures, prevalent exposures, and causal inference: does limiting studies to persons who are followed from first exposure onward damage epidemiology?
Am J Epidemiol. 2015 Nov 15;182(10):826-33. doi: 10.1093/aje/kwv225. Epub 2015 Oct 26.
3
Confounding in health research.
Annu Rev Public Health. 2001;22:189-212. doi: 10.1146/annurev.publhealth.22.1.189.
4
Counterpoint: epidemiology to guide decision-making: moving away from practice-free research.
Am J Epidemiol. 2015 Nov 15;182(10):834-9. doi: 10.1093/aje/kwv215. Epub 2015 Oct 26.
5
Risk relativism and physical law.
J Epidemiol Community Health. 2015 Jan;69(1):92-4. doi: 10.1136/jech-2014-204347. Epub 2014 Aug 14.
6
Interpretation of low to moderate relative risks in environmental epidemiologic studies.
Annu Rev Public Health. 1994;15:179-201. doi: 10.1146/annurev.pu.15.050194.001143.
7
[Interpretation of epidemiologic studies. Type of study, elements of bias, causality].
Rev Prat. 1999 Oct 15;49(16):1797-804.
8
[Methods for causal inference in epidemiology].
Epidemiol Prev. 2010 Jan-Apr;34(1-2):5-6.
9
Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy. Part 1. Principles of causality in epidemiological research: time order, specification of the study base and specificity.
J Fam Plann Reprod Health Care. 2008 Apr;34(2):83-7.
10
The association of body mass index with health outcomes: causal, inconsistent, or confounded?
Am J Epidemiol. 2009 Oct 15;170(8):957-8. doi: 10.1093/aje/kwp292. Epub 2009 Sep 15.
引用本文的文献
1
Risk factors for nephropathy in individuals with new-onset type 2 diabetes undergoing treatment for hypertension: A retrospective analysis using the Diagnosis Procedure Combination database.
Ann Clin Epidemiol. 2025 Feb 11;7(3):71-79. doi: 10.37737/ace.25009. eCollection 2025 Jul 1.
2
Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998-2016.
J Allergy Clin Immunol. 2021 May;147(5):1753-1763. doi: 10.1016/j.jaci.2020.12.001. Epub 2021 Jan 27.
3
Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi-ethnic population.
J Diabetes Investig. 2021 Jul;12(7):1175-1182. doi: 10.1111/jdi.13464. Epub 2020 Dec 15.
4
Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study.
BMJ. 2018 May 23;361:k1786. doi: 10.1136/bmj.k1786.
5
Methodologic Issues When Estimating Risks in Pharmacoepidemiology.
Curr Epidemiol Rep. 2016 Dec;3(4):285-296. doi: 10.1007/s40471-016-0089-1. Epub 2016 Sep 13.
本文引用的文献
1
Counterpoint: the treatment decision design.
Am J Epidemiol. 2015 Nov 15;182(10):840-5. doi: 10.1093/aje/kwv214. Epub 2015 Oct 26.
2
Counterpoint: epidemiology to guide decision-making: moving away from practice-free research.
Am J Epidemiol. 2015 Nov 15;182(10):834-9. doi: 10.1093/aje/kwv215. Epub 2015 Oct 26.
3
Point: incident exposures, prevalent exposures, and causal inference: does limiting studies to persons who are followed from first exposure onward damage epidemiology?
Am J Epidemiol. 2015 Nov 15;182(10):826-33. doi: 10.1093/aje/kwv225. Epub 2015 Oct 26.
Zotero 插件